Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Cipla Limited
CIPLACipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India. Address: Cipla House, Mumbai, India, 400013
Analytics
WallStreetin tavoitehinta
123 445.22 INRP/E-suhde
28.3376Osinkotuotto
0.83 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut CIPLA
Osinkoanalytiikka CIPLA
Osinkojen kasvu 5 vuoden aikana
183 %Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
16 %Osinkohistoria CIPLA
Osakkeen arvostus CIPLA
Talousasiat CIPLA
Tuloksia | 2019 | Dynamiikka |